NFA
AERI

Nationwide Fund Advisors’s Aerie Pharmaceuticals AERI Stock Holding History

Nationwide Fund Advisors’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-71,609
Closed -$3.48M – 2418
2017
Q3 		$3.48M Buy
71,609
+10,382
+17% +$566K 0.01% 1185
2017
Q2 		$3.22M Buy
61,227
+9,104
+17% +$424K 0.01% 1225
2017
Q1 		$2.36M Sell
52,123
-3,530
-6% -$157K 0.01% 1326
2016
Q4 		$2.11M Sell
55,653
-5,500
-9% -$208K 0.01% 1386
2016
Q3 		$2.31M Sell
61,153
-18,320
-23% -$404K 0.01% 1319
2016
Q2 		$1.4M Buy
79,473
+2,490
+3% +$40.3K 0.01% 1535
2016
Q1 		$936K Buy
76,983
+20,905
+37% +$331K ﹤0.01% 1758
2015
Q4 		$1.36M Buy
56,078
+20,265
+57% +$473K 0.01% 1559
2015
Q3 		$635K Hold
35,813
– – ﹤0.01% 1964
2015
Q2 		$632K Buy
35,813
+5,574
+18% +$102K ﹤0.01% 2119
2015
Q1 		$948K Sell
30,239
-212
-0.7% -$6.14K ﹤0.01% 1913
2014
Q4 		$889K Sell
30,451
-73
-0.2% -$1.85K ﹤0.01% 1869
2014
Q3 		$632K Buy
30,524
+3,238
+12% +$63.8K ﹤0.01% 2070
2014
Q2 		$676K Buy
27,286
+2,093
+8% +$36.3K ﹤0.01% 2094
2014
Q1 		$534K Buy
25,193
+19,398
+335% +$392K ﹤0.01% 2032
2013
Q4 		$104K Buy
+5,795
New +$75.5K ﹤0.01% 2942

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nationwide Fund Advisors's AERI Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Aerie Pharmaceuticals (AERI) in Q4 2017, closing a stake of 71,609 shares — an estimated $3.48M sold.

Nationwide Fund Advisors first reported a position in AERI in Q4 2013 and held it in 16 quarters. The position peaked at $3.48M in Q3 2017. 179 funds tracked by Wall St. Rank hold AERI as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Aerie Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 71,609 Aerie Pharmaceuticals shares in Q4 2017, an estimated $3.48M.
  • Nationwide Fund Advisors first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 16 quarters.
  • Nationwide Fund Advisors's Aerie Pharmaceuticals position peaked at $3.48M in Q3 2017.
  • 179 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.